| dc.contributor.author | Masilela, Charity | |
| dc.contributor.author | Adeniyi, Oladele Vincent | |
| dc.contributor.author | Benjeddou, Mongi | |
| dc.date.accessioned | 2022-09-05T12:24:11Z | |
| dc.date.available | 2022-09-05T12:24:11Z | |
| dc.date.issued | 2022 | |
| dc.identifier.citation | Masilela, C. et al. (2022). Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities. Scientific Reports,12, 337. https://doi.org/10.1038/s41598-021-04150-6 | en_US |
| dc.identifier.issn | 2045-2322 | |
| dc.identifier.uri | https://doi.org/10.1038/s41598-021-04150-6 | |
| dc.identifier.uri | http://hdl.handle.net/10566/7801 | |
| dc.description.abstract | The present study assessed the prevalence, patterns and determinants of dyslipidaemia among South African adults with multi-morbidities. In this study, 614 individuals with DM and hypertension were recruited. Dyslipidaemia was defined as elevated levels of total cholesterol (TC) ≥ 5.2 mmol/L and/or low-density lipoprotein cholesterol (LDL-C) ≥ 2.6 mmol/L, triglycerides (TG) ≥ 1.8 mmol/L and low high-density lipoprotein cholesterol (HDL-C) < 1 mmol/L for men and < 1.2 mmol/L for women. Multivariate regression model (adjusted) analysis was used to identify the significant determinants of dyslipidaemia. The prevalence of dyslipidaemia was 76.7% (n = 471), with females showing the highest prevalence 357 (75.79%). | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Nature Research | en_US |
| dc.subject | Biotechnology | en_US |
| dc.subject | Health care | en_US |
| dc.subject | Diseases | en_US |
| dc.subject | Medical research | en_US |
| dc.subject | Dyslipidaemia | en_US |
| dc.subject | South Africa | en_US |
| dc.title | Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities | en_US |
| dc.type | Article | en_US |
